help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Streit, M.
Right arrow Articles by Detmar, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Streit, M.
Right arrow Articles by Detmar, M.
(American Journal of Pathology. 1999;155:441-452.)
© 1999 American Society for Investigative Pathology

Regular Articles

Overexpression of Thrombospondin-1 Decreases Angiogenesis and Inhibits the Growth of Human Cutaneous Squamous Cell Carcinomas

Michael Streit*, Paula Velasco*, Lawrence F. Brown{dagger}, Mihaela Skobe*, Lisa Richard*, Lucia Riccardi*, Jack Lawler{dagger} and Michael Detmar*

From the Cutaneous Biology Research Center, Department of Dermatology,*
Massachusetts General Hospital and Harvard Medical School, Charlestown; and the Department of Pathology,{dagger}
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

The function of the endogenous angiogenesis inhibitor thrombospondin-1 (TSP-1) in epithelial tumor development has remained controversial. We studied the in vitro growth characteristics and the in vivo tumor xenograft growth of the human squamous cell carcinoma cell lines A431 and SCC-13, stably transfected to overexpress human TSP-1. Overexpression of TSP-1 inhibited tumor growth of A431 xenotransplants, and completely abolished tumor formation by SCC-13 cells. TSP-1 overexpressing A431 tumors were characterized by extensive areas of necrosis and by decreased tumor vessel number and size. The effects of TSP-1 on tumor cell growth were indirect since tumor cell proliferation rates in vivo and in vitro, anchorage-dependent and -independent growth in vitro, and susceptibility to induction of apoptosis by serum withdrawal were unchanged in TSP-1 overexpressing tumor cells. However, TSP-1 overexpression up-regulated the TSP-1 receptor CD36, leading to enhanced adhesion of A431 cells to TSP-1. These findings establish TSP-1 as a potent inhibitor of angiogenesis and tumor growth in carcinomas of the skin.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M.-P. Wu, M.-J. Young, C.-C. Tzeng, C.-R. Tzeng, K.-F. Huang, L.-W. Wu, and C.-Y. Chou
A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer
Carcinogenesis, June 1, 2008; 29(6): 1115 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. G. Sreekumar, J. Zhou, J. Sohn, C. Spee, S. J. Ryan, B. J. Maurer, R. Kannan, and D. R. Hinton
N-(4-hydroxyphenyl) Retinamide Augments Laser-Induced Choroidal Neovascularization in Mice
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1210 - 1220.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
Y. Hashimoto, M. Parsons, and J. C. Adams
Dual Actin-bundling and Protein Kinase C-binding Activities of Fascin Regulate Carcinoma Cell Migration Downstream of Rac and Contribute to Metastasis
Mol. Biol. Cell, November 1, 2007; 18(11): 4591 - 4602.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Z. Li, C. Wang, X. Jiao, Y. Lu, M. Fu, A. A. Quong, C. Dye, J. Yang, M. Dai, X. Ju, et al.
Cyclin D1 Regulates Cellular Migration through the Inhibition of Thrombospondin 1 and ROCK Signaling.
Mol. Cell. Biol., June 1, 2006; 26(11): 4240 - 4256.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Masli, B. Turpie, and J W. Streilein
Thrombospondin orchestrates the tolerance-promoting properties of TGF{beta}-treated antigen-presenting cells
Int. Immunol., May 1, 2006; 18(5): 689 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. Zhang, E. Galardi, M. Duquette, J. Lawler, and S. Parangi
Antiangiogenic Treatment with Three Thrombospondin-1 Type 1 Repeats versus Gemcitabine in an Orthotopic Human Pancreatic Cancer Model
Clin. Cancer Res., August 1, 2005; 11(15): 5622 - 5630.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
N. G. Frangogiannis, G. Ren, O. Dewald, P. Zymek, S. Haudek, A. Koerting, K. Winkelmann, L. H. Michael, J. Lawler, and M. L. Entman
Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts
Circulation, June 7, 2005; 111(22): 2935 - 2942.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Nyberg, L. Xie, and R. Kalluri
Endogenous Inhibitors of Angiogenesis
Cancer Res., May 15, 2005; 65(10): 3967 - 3979.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. Zhang, E. Galardi, M. Duquette, M. Delic, J. Lawler, and S. Parangi
Antiangiogenic Treatment with the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein in an Orthotopic Human Pancreatic Cancer Model
Clin. Cancer Res., March 15, 2005; 11(6): 2337 - 2344.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Pohl, C.-L. Ho, R. J. Kurman, R. Bristow, T.-L. Wang, and I.-M. Shih
Inactivation of the Mitogen-Activated Protein Kinase Pathway as a Potential Target-Based Therapy in Ovarian Serous Tumors with KRAS or BRAF Mutations
Cancer Res., March 1, 2005; 65(5): 1994 - 2000.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Sund, Y. Hamano, H. Sugimoto, A. Sudhakar, M. Soubasakos, U. Yerramalla, L. E. Benjamin, J. Lawler, M. Kieran, A. Shah, et al.
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
PNAS, February 22, 2005; 102(8): 2934 - 2939.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
F. G. Spinale
Cell-Matrix Signaling and Thrombospondin: Another Link to Myocardial Matrix Remodeling
Circ. Res., September 3, 2004; 95(5): 446 - 448.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Adams, G. T. Miller, M. I. Jesson, T. Watanabe, B. Jones, and B. P. Wallner
PT-100, a Small Molecule Dipeptidyl Peptidase Inhibitor, Has Potent Antitumor Effects and Augments Antibody-Mediated Cytotoxicity via a Novel Immune Mechanism
Cancer Res., August 1, 2004; 64(15): 5471 - 5480.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. O. Yee, M. Streit, T. Hawighorst, M. Detmar, and J. Lawler
Expression of the Type-1 Repeats of Thrombospondin-1 Inhibits Tumor Growth Through Activation of Transforming Growth Factor-{beta}
Am. J. Pathol., August 1, 2004; 165(2): 541 - 552.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Segrelles, S. Ruiz, M. Santos, J. Martinez-Palacio, M. F. Lara, and J. M. Paramio
Akt mediates an angiogenic switch in transformed keratinocytes
Carcinogenesis, July 1, 2004; 25(7): 1137 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. T. Poon, K. K. Chung, S. T. Cheung, C. P. Lau, S. W. Tong, K. L. Leung, W. C. Yu, G. P. Tuszynski, and S. T. Fan
Clinical Significance of Thrombospondin 1 Expression in Hepatocellular Carcinoma
Clin. Cancer Res., June 15, 2004; 10(12): 4150 - 4157.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
V. Chhokar and A. L. Tucker
Angiogenesis: Basic Mechanisms and Clinical Applications
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 253 - 280.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
E. K. Rofstad, K. Henriksen, K. Galappathi, and B. Mathiesen
Antiangiogenic Treatment with Thrombospondin-1 Enhances Primary Tumor Radiation Response and Prevents Growth of Dormant Pulmonary Micrometastases after Curative Radiation Therapy in Human Melanoma Xenografts
Cancer Res., July 15, 2003; 63(14): 4055 - 4061.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. S. Gutierrez, M. Suckow, J. Lawler, V. A. Ploplis, and F. J. Castellino
Thrombospondin 1--a regulator of adenoma growth and carcinoma progression in the APCMin/+ mouse model
Carcinogenesis, February 1, 2003; 24(2): 199 - 207.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Oura, J. Bertoncini, P. Velasco, L. F. Brown, P. Carmeliet, and M. Detmar
A critical role of placental growth factor in the induction of inflammation and edema formation
Blood, January 15, 2003; 101(2): 560 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Agah, T. R. Kyriakides, J. Lawler, and P. Bornstein
The Lack of Thrombospondin-1 (TSP1) Dictates the Course of Wound Healing in Double-TSP1/TSP2-Null Mice
Am. J. Pathol., September 1, 2002; 161(3): 831 - 839.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Tanaka, H. Sonoo, J. Kurebayashi, T. Nomura, S. Ohkubo, Y. Yamamoto, and S. Yamamoto
Inhibition of Infiltration and Angiogenesis by Thrombospondin-1 in Papillary Thyroid Carcinoma
Clin. Cancer Res., May 1, 2002; 8(5): 1125 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Streit, A. E. Stephen, T. Hawighorst, K. Matsuda, B. Lange-Asschenfeldt, L. F. Brown, J. P. Vacanti, and M. Detmar
Systemic Inhibition of Tumor Growth and Angiogenesis by Thrombospondin-2 Using Cell-based Antiangiogenic Gene Therapy
Cancer Res., April 1, 2002; 62(7): 2004 - 2012.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Hawighorst, M. Skobe, M. Streit, Y.-K. Hong, P. Velasco, L. F. Brown, L. Riccardi, B. Lange-Asschenfeldt, and M. Detmar
Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth
Am. J. Pathol., April 1, 2002; 160(4): 1381 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Kragh, B. Quistorff, M. Tenan, E. G. Van Meir, and E. G. Kristjansen
Overexpression of Thrombospondin-1 Reduces Growth and Vascular Index but not Perfusion in Glioblastoma
Cancer Res., February 1, 2002; 62(4): 1191 - 1195.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Lange-Asschenfeldt, W. Weninger, P. Velasco, T. R. Kyriakides, U. H. von Andrian, P. Bornstein, and M. Detmar
Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice
Blood, January 15, 2002; 99(2): 538 - 545.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W.-M. Miao, W. Lin Seng, M. Duquette, P. Lawler, C. Laus, and J. Lawler
Thrombospondin-1 Type 1 Repeat Recombinant Proteins Inhibit Tumor Growth through Transforming Growth Factor-{beta}-dependent and -independent Mechanisms
Cancer Res., November 1, 2001; 61(21): 7830 - 7839.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Lawler, W.-M. Miao, M. Duquette, N. Bouck, R. T. Bronson, and R. O. Hynes
Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice
Am. J. Pathol., November 1, 2001; 159(5): 1949 - 1956.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. C. Rodriguez-Manzaneque, T. F. Lane, M. A. Ortega, R. O. Hynes, J. Lawler, and M. L. Iruela-Arispe
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
PNAS, October 12, 2001; (2001) 171460498.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Molecular Pathology of Cyclooxygenase-2 in Cancer-induced Angiogenesis
Ann. Clin. Lab. Sci., October 1, 2001; 31(4): 325 - 348.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
U. Graeven, U. Rodeck, S. Karpinski, M. Jost, S. Philippou, and W. Schmiegel
Modulation of Angiogenesis and Tumorigenicity of Human Melanocytic Cells by Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor
Cancer Res., October 1, 2001; 61(19): 7282 - 7290.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. H. Weeks, W. He, K. L. Olson, and X.-J. Wang
Inducible Expression of Transforming Growth Factor {beta}1 in Papillomas Causes Rapid Metastasis
Cancer Res., October 1, 2001; 61(20): 7435 - 7443.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
I. Sargiannidou, J. Zhou, and G. P. Tuszynski
The Role of Thrombospondin-1 in Tumor Progression
Experimental Biology and Medicine, September 1, 2001; 226(8): 726 - 733.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S. Filleur, O. V. Volpert, A. Degeorges, C. Voland, F. Reiher, P. Clezardin, N. Bouck, and F. Cabon
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects
Genes & Dev., June 1, 2001; 15(11): 1373 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. de Fraipont, M. El Atifi, C. Gicquel, X. Bertagna, E. M. Chambaz, and J. J. Feige
Expression of the Angiogenesis Markers Vascular Endothelial Growth Factor-A, Thrombospondin-1, and Platelet-Derived Endothelial Cell Growth Factor in Human Sporadic Adrenocortical Tumors: Correlation with Genotypic Alterations
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4734 - 4741.
[Abstract] [Full Text]

Home page
 FASEB J.Home page
M. RUSNATI, G. TARABOLETTI, C. URBINATI, G. TULIPANO, R. GIULIANI, M. P. MOLINARI-TOSATTI, B. SENNINO, M. GIACCA, M. TYAGI, A. ALBINI, et al.
Thrombospondin-1/HIV-1 Tat protein interaction: modulation of the biological activity of extracellular Tat
FASEB J, October 1, 2000; 14(13): 1917 - 1930.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
K. R. Laderoute, R. M. Alarcon, M. D. Brody, J. M. Calaoagan, E. Y. Chen, A. M. Knapp, Z. Yun, N. C. Denko, and A. J. Giaccia
Opposing Effects of Hypoxia on Expression of the Angiogenic Inhibitor Thrombospondin 1 and the Angiogenic Inducer Vascular Endothelial Growth Factor
Clin. Cancer Res., July 1, 2000; 6(7): 2941 - 2950.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
M. Detmar, P. Velasco, L. Richard, K. P. Claffey, M. Streit, L. Riccardi, M. Skobe, and L. F. Brown
Expression of Vascular Endothelial Growth Factor Induces an Invasive Phenotype in Human Squamous Cell Carcinomas
Am. J. Pathol., January 1, 2000; 156(1): 159 - 167.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Streit, L. Riccardi, P. Velasco, L. F. Brown, T. Hawighorst, P. Bornstein, and M. Detmar
Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
PNAS, December 21, 1999; 96(26): 14888 - 14893.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. C. Rodriguez-Manzaneque, T. F. Lane, M. A. Ortega, R. O. Hynes, J. Lawler, and M. L. Iruela-Arispe
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
PNAS, October 23, 2001; 98(22): 12485 - 12490.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.